Mr. Cruz (for himself, Mr. Johnson, and Mr. Lee) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
To amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019. S. 2161. 116th
Cong., 1st
sess., Introduced in Senate July 18, 2019. https://www.govinfo.gov/app/details/BILLS-116s2161is.
APA
Congress, Senate (2019, July 18). Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019 (S. 2161 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-116s2161is.
MLA
United States, Congress, Senate. Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-116s2161is. 116th Congress, S. 2161, Introduced in Senate 18 Jul. 2019.
Bluebook
S.2161 - 116th Congress (2019-2020): Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019, S.2161, 116th Cong. (2019), https://www.govinfo.gov/app/details/BILLS-116s2161is.
